News

That’s because for years, target date funds have been overweight in international stocks, said Jason Kephart, a senior principal of multi-asset strategy ratings at Morningstar. Compared to all ...
Malignant peripheral nerve sheath tumors (MPNSTs) are neoplasms of Schwann cells that represent approximately 5% of soft tissue sarcoma (STS) diagnoses each year. Patients with neurofibromatosis type ...
Morningstar’s senior principal for multi-asset strategy ratings Jason Kephart discusses the portfolio benefits that private assets can provide, the hurdles asset managers will face to see ...
Fidelity Blue Chip Growth’s excellent leadership and skillful execution continue to be advantages, but the fund is vulnerable if current enthusiasm for artificial intelligence wanes or ...
When markets get volatile, low-volatility exchange-traded funds and mutual funds get attention. While the notice is warranted—they’ve been among the more buoyant strategies since consternation ...
Bryan Armour: John F. Kennedy once said, “The best time to repair the roof is when the sun is shining.” The sun isn’t currently shining on US stocks, but we’re not in the middle of a ...
Abstract: An MHD simulation of a plasma coaxial accelerator was developed to study the sheath dynamics and various properties. This work presents the effect of the viscous force on the plasma sheath ...
Born July 9, 1942, in Lock Haven, she was a daughter of the late Robert and Vandetta Kephart Fisher. Jean attended Jersey Shore High School. She was employed as a waitress at the former Boron ...
While a lot of attention is focused on US mega-cap growth stocks, other segments of the market have been quietly ticking along, at least in a relative sense. One is value stocks outside the US ...
Susan Dziubinski: So that’s a look at the funds and the investments. Now, you and I sat down about six months ago after Vanguard announced that it had brought in a new CEO from BlackRock, Salim ...
And what questions should you be asking before you buy one? Here with me to unpack it all is Jason Kephart. Jason is a senior principal with Morningstar’s multi-asset team. Hey, Jason.